Cargando…

Transcriptome profiling analysis reveals that ATP6V0E2 is involved in the lysosomal activation by anlotinib

Anlotinib is a receptor tyrosine kinase inhibitor with potential anti-neoplastic and anti-angiogenic activities. It has been approved for the treatment of non-small-cell lung cancer. Lysosomes are acidic organelles and have been implicated in various mechanisms of cancer therapeutics. However, the e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Xin, Shu, Yuhan, Yan, Peiyi, Huang, Hongliang, Gao, Ruilan, Xu, Mengting, Lu, Liqin, Tian, Jingkui, Huang, Dongsheng, Zhang, Jianbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445181/ https://www.ncbi.nlm.nih.gov/pubmed/32839434 http://dx.doi.org/10.1038/s41419-020-02904-0

Ejemplares similares

A Novel Benzofuran Derivative Moracin N Induces Autophagy and Apoptosis Through ROS Generation in Lung Cancer
por: Gao, Chengcheng, et al.
Publicado: (2020)

Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylation-mediated mitophagy
por: Sun, Xin, et al.
Publicado: (2022)

A Quassinoid Diterpenoid Eurycomanone from Eurycoma longifolia Jack Exerts Anti-Cancer Effect through Autophagy Inhibition
por: Ye, Guiqin, et al.
Publicado: (2022)

Docetaxel enhances lysosomal function through TFEB activation
por: Zhang, Jianbin, et al.
Publicado: (2018)

DHOK Exerts Anti-Cancer Effect Through Autophagy Inhibition in Colorectal Cancer
por: Shu, Yuhan, et al.
Publicado: (2021)

The involvement of Parkin-dependent mitophagy in the anti-cancer activity of Ginsenoside
por: Sun, Xin, et al.
Publicado: (2022)

ANXA6 suppresses the tumorigenesis of cervical cancer through autophagy induction
por: Sun, Xin, et al.
Publicado: (2020)

Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells
por: Lu, Jun, et al.
Publicado: (2019)

Correction: Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells
por: Lu, Jun, et al.
Publicado: (2022)

ATP13A2 facilitates HDAC6 recruitment to lysosome to promote autophagosome–lysosome fusion
por: Wang, Ruoxi, et al.
Publicado: (2019)

Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma
por: Shi, Jingzhen, et al.
Publicado: (2020)

Multi-Omics Analysis of Anlotinib in Pancreatic Cancer and Development of an Anlotinib-Related Prognostic Signature
por: Zhang, Xi, et al.
Publicado: (2021)

Corrigendum: Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma
por: Shi, Jingzhen, et al.
Publicado: (2020)

Safety and Efficacy of Chemotherapy Combined with Anlotinib Plus Anlotinib Maintenance in Chinese Patients with Advanced/Metastatic Soft Tissue Sarcoma
por: Wang, Hai-ying, et al.
Publicado: (2020)

Efficacy and Safety of Anlotinib Combined with Liposomal Doxorubicin Followed by Anlotinib Maintenance in Metastatic Soft Tissue Sarcomas
por: Liu, Zhiyong, et al.
Publicado: (2021)

Possible Involvement of F1F0-ATP synthase and Intracellular ATP in Keratinocyte Differentiation in normal skin and skin lesions
por: Xiaoyun, Xie, et al.
Publicado: (2017)

Antitumor effects of anlotinib in thyroid cancer
por: Ruan, Xianhui, et al.
Publicado: (2018)

Hypertensive Retinopathy Secondary to Anlotinib Treatment
por: Zhang, Xiaohua, et al.
Publicado: (2020)

De novo Transcriptome Analysis Revealed the Putative Pathway Genes Involved in Biosynthesis of Moracins in Morus alba L.
por: Liu, Shengzhi, et al.
Publicado: (2022)

Lysosomal ATP Transporter SLC17A9 Controls Cell Viability via Regulating Cathepsin D
por: Huang, Peng, et al.
Publicado: (2022)

ATP6V0C Knockdown in Neuroblastoma Cells Alters Autophagy-Lysosome Pathway Function and Metabolism of Proteins that Accumulate in Neurodegenerative Disease
por: Mangieri, Leandra R., et al.
Publicado: (2014)

The phospholipid flippase ATP8B1 is required for lysosomal fusion in macrophages
por: Gómez‐Mellado, Valentina E., et al.
Publicado: (2022)

Tislelizumab combined with anlotinib in the second-line treatment of malignant pleural mesothelioma
por: Zhang, Dandan, et al.
Publicado: (2022)

Bronchial Fistula: Rare Complication of Treatment with Anlotinib
por: DENG, Pengbo, et al.
Publicado: (2020)

Efficacy of Anlotinib for the Treatment of Angiosarcoma of the Face and Neck: A Case Report
por: Ren, Biyong, et al.
Publicado: (2021)

The Combination of Anlotinib and Gemcitabine/Docetaxel in Patients with Metastatic Osteosarcoma Who Have Failed Standard Chemotherapy
por: Wang, Tian, et al.
Publicado: (2022)

Combination of anlotinib and gemcitabine promotes the G0/G1 cell cycle arrest and apoptosis of intrahepatic cholangiocarcinoma in vitro
por: Fan, Shanshan, et al.
Publicado: (2021)

Involvement of Lysosomal Labilisation and Lysosomal/mitochondrial Cross-Talk in Diclofenac Induced Hepatotoxicity
por: Pourahmad, Jalal, et al.
Publicado: (2011)

Clinical Application of Anlotinib Combined with Docetaxel: Safe and Effective Treatment for Lung Carcinoma
por: Ji, Xiang, et al.
Publicado: (2022)

The Involvement of Lysosomes in Myocardial Aging and Disease
por: Terman, Alexei, et al.
Publicado: (2008)

The Efficacy and Safety of Anlotinib in Pediatric Patients With Refractory or Recurrent Solid Tumors
por: Lu, Suying, et al.
Publicado: (2022)

ATP Release through Lysosomal Exocytosis from Peripheral Nerves: The Effect of Lysosomal Exocytosis on Peripheral Nerve Degeneration and Regeneration after Nerve Injury
por: Jung, Junyang, et al.
Publicado: (2014)

Data for transcriptomic and proteomic analyses of leaves from Clematis terniflora DC. under binary stress
por: Yang, Bingxian, et al.
Publicado: (2017)

The relationship between treatment-induced hypertension and efficacy of anlotinib in recurrent or metastatic esophageal squamous cell carcinoma
por: Song, Yan, et al.
Publicado: (2021)

Anlotinib suppresses lung adenocarcinoma growth via inhibiting FASN-mediated lipid metabolism
por: Shen, Juan, et al.
Publicado: (2022)

Autophagic blockade potentiates anlotinib-mediated ferroptosis in anaplastic thyroid cancer
por: Wu, Jiajun, et al.
Publicado: (2023)

The efficacy and safety of anlotinib treatment for advanced lung cancer
por: Shao, Lan, et al.
Publicado: (2019)

Anlotinib Downregulates RGC32 Which Provoked by Bevacizumab
por: Liu, Zhujun, et al.
Publicado: (2022)

Salvage treatment with anlotinib for advanced non‐small cell lung cancer
por: Wu, Di, et al.
Publicado: (2019)

Wilson Disease Protein ATP7B Utilizes Lysosomal Exocytosis to Maintain Copper Homeostasis
por: Polishchuk, Elena V., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_38g3lebl7ctdk1p4g535hnu2si